Cargando…
Identification and Characterization of Mechanism of Action of P61-E7, a Novel Phosphine Catalysis-Based Inhibitor of Geranylgeranyltransferase-I
Small molecule inhibitors of protein geranylgeranyltransferase-I (GGTase-I) provide a promising type of anticancer drugs. Here, we first report the identification of a novel tetrahydropyridine scaffold compound, P61-E7, and define effects of this compound on pancreatic cancer cells. P61-E7 was ident...
Autores principales: | Chan, Lai N., Fiji, Hannah D. G., Watanabe, Masaru, Kwon, Ohyun, Tamanoi, Fuyuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196516/ https://www.ncbi.nlm.nih.gov/pubmed/22028818 http://dx.doi.org/10.1371/journal.pone.0026135 |
Ejemplares similares
-
In vitro and in vivo effects of geranylgeranyltransferase I inhibitor P61A6 on non-small cell lung cancer cells
por: Zimonjic, Drazen B, et al.
Publicado: (2013) -
Nanoformulation of Geranylgeranyltransferase-I Inhibitors for Cancer Therapy: Liposomal Encapsulation and pH-Dependent Delivery to Cancer Cells
por: Lu, Jie, et al.
Publicado: (2015) -
Geranylgeranyltransferase I is essential for dendritic development of cerebellar Purkinje cells
por: Wu, Kong-Yan, et al.
Publicado: (2010) -
Chiral phosphines in nucleophilic organocatalysis
por: Xiao, Yumei, et al.
Publicado: (2014) -
Synergistic Effect of Geranylgeranyltransferase Inhibitor, GGTI, and Docetaxel on the Growth of Prostate Cancer Cells
por: Han, Bin, et al.
Publicado: (2012)